Cargando…

Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus

OBJECTIVE: To investigate the application value of 3T MRI qDixon-WIP technique in the quantitative measurement of pancreatic fat content in patients with type 2 diabetes mellitus (T2DM). METHODS: The 3T MRI qDixon-WIP sequence was used to scan the livers and the pancreas of 47 T2DM patients (experim...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jixing, Xu, Fengming, Li, Tao, Liang, Bumin, Li, Shu, Feng, Qing, Long, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981945/
https://www.ncbi.nlm.nih.gov/pubmed/36875489
http://dx.doi.org/10.3389/fendo.2023.1140111
_version_ 1784900217233997824
author Yi, Jixing
Xu, Fengming
Li, Tao
Liang, Bumin
Li, Shu
Feng, Qing
Long, Liling
author_facet Yi, Jixing
Xu, Fengming
Li, Tao
Liang, Bumin
Li, Shu
Feng, Qing
Long, Liling
author_sort Yi, Jixing
collection PubMed
description OBJECTIVE: To investigate the application value of 3T MRI qDixon-WIP technique in the quantitative measurement of pancreatic fat content in patients with type 2 diabetes mellitus (T2DM). METHODS: The 3T MRI qDixon-WIP sequence was used to scan the livers and the pancreas of 47 T2DM patients (experimental group) and 48 healthy volunteers (control group). Pancreatic fat fraction (PFF), hepatic fat fraction (HFF), Body mass index (BMI) ratio of pancreatic volume to body surface area (PVI) were measured. Total cholesterol (TC), subcutaneous fat area (SA), triglyceride (TG), abdominal visceral fat area (VA), high density lipoprotein (HDL-c), fasting blood glucose (FPC) and low-density lipoprotein (LDL-c) were collected. The relationship between the experimental group and the control group and between PFF and other indicators was compared. The differences of PFF between the control group and different disease course subgroups were also explored. RESULTS: There was no significant difference in BMI between the experimental group and the control group (P=0.231). PVI, SA, VA, PFF and HFF had statistical differences (P<0.05). In the experimental group, PFF was highly positively correlated with HFF (r=0.964, P<0.001), it was moderately positively correlated with TG and abdominal fat area (r=0.676, 0.591, P<0.001), and it was weakly positively correlated with subcutaneous fat area (r=0.321, P=0.033). And it had no correlation with FPC, PVI, HDL-c, TC and LDL-c (P>0.05). There were statistical differences in PFF between the control group and the patients with different course of T2DM (P<0.05). There was no significant difference in PFF between T2DM patients with a disease course ≤1 year and those with a disease course <5 years (P>0.05). There were significant differences in PFF between the groups with a disease course of 1-5 years and those with a disease course of more than 5 years (P<0.001). CONCLUSION: PVI of T2DM patients is lower than normal, but SA, VA, PFF, HFF are higher than normal. The degree of pancreatic fat accumulation in T2DM patients with long disease course was higher than that in patients with short disease course. The qDixon-WIP sequence can provide an important reference for clinical quantitative evaluation of fat content in T2DM patients.
format Online
Article
Text
id pubmed-9981945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99819452023-03-04 Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus Yi, Jixing Xu, Fengming Li, Tao Liang, Bumin Li, Shu Feng, Qing Long, Liling Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To investigate the application value of 3T MRI qDixon-WIP technique in the quantitative measurement of pancreatic fat content in patients with type 2 diabetes mellitus (T2DM). METHODS: The 3T MRI qDixon-WIP sequence was used to scan the livers and the pancreas of 47 T2DM patients (experimental group) and 48 healthy volunteers (control group). Pancreatic fat fraction (PFF), hepatic fat fraction (HFF), Body mass index (BMI) ratio of pancreatic volume to body surface area (PVI) were measured. Total cholesterol (TC), subcutaneous fat area (SA), triglyceride (TG), abdominal visceral fat area (VA), high density lipoprotein (HDL-c), fasting blood glucose (FPC) and low-density lipoprotein (LDL-c) were collected. The relationship between the experimental group and the control group and between PFF and other indicators was compared. The differences of PFF between the control group and different disease course subgroups were also explored. RESULTS: There was no significant difference in BMI between the experimental group and the control group (P=0.231). PVI, SA, VA, PFF and HFF had statistical differences (P<0.05). In the experimental group, PFF was highly positively correlated with HFF (r=0.964, P<0.001), it was moderately positively correlated with TG and abdominal fat area (r=0.676, 0.591, P<0.001), and it was weakly positively correlated with subcutaneous fat area (r=0.321, P=0.033). And it had no correlation with FPC, PVI, HDL-c, TC and LDL-c (P>0.05). There were statistical differences in PFF between the control group and the patients with different course of T2DM (P<0.05). There was no significant difference in PFF between T2DM patients with a disease course ≤1 year and those with a disease course <5 years (P>0.05). There were significant differences in PFF between the groups with a disease course of 1-5 years and those with a disease course of more than 5 years (P<0.001). CONCLUSION: PVI of T2DM patients is lower than normal, but SA, VA, PFF, HFF are higher than normal. The degree of pancreatic fat accumulation in T2DM patients with long disease course was higher than that in patients with short disease course. The qDixon-WIP sequence can provide an important reference for clinical quantitative evaluation of fat content in T2DM patients. Frontiers Media S.A. 2023-02-17 /pmc/articles/PMC9981945/ /pubmed/36875489 http://dx.doi.org/10.3389/fendo.2023.1140111 Text en Copyright © 2023 Yi, Xu, Li, Liang, Li, Feng and Long https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yi, Jixing
Xu, Fengming
Li, Tao
Liang, Bumin
Li, Shu
Feng, Qing
Long, Liling
Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title_full Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title_fullStr Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title_full_unstemmed Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title_short Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
title_sort quantitative study of 3t mri qdixon-wip applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981945/
https://www.ncbi.nlm.nih.gov/pubmed/36875489
http://dx.doi.org/10.3389/fendo.2023.1140111
work_keys_str_mv AT yijixing quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT xufengming quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT litao quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT liangbumin quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT lishu quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT fengqing quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus
AT longliling quantitativestudyof3tmriqdixonwipappliedinpancreaticfatinfiltrationinpatientswithtype2diabetesmellitus